Skip to main content

Peer Review reports

From: CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdown

Original Submission
18 Feb 2023 Submitted Original manuscript
4 Apr 2023 Reviewed Reviewer Report
7 Apr 2023 Reviewed Reviewer Report
19 May 2023 Author responded Author comments - Xinwei Han
Resubmission - Version 2
19 May 2023 Submitted Manuscript version 2
8 Jun 2023 Reviewed Reviewer Report
28 Jun 2023 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
29 Jun 2023 Editorially accepted
14 Aug 2023 Article published 10.1186/s12885-023-11131-7

You can find further information about peer review here.

Back to article page